Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
The Journal of Dermatology|January 3, 2023
A case of Cockayne syndrome with unusually mild clinical manifestationsMariko Tsujimoto, Eiji Nakano, Yuka Nakazawa, et al.Rinsho Shinkeigaku = Clinical Neurology|July 2, 2023
[Cingulate seizure as a clinical manifestation of anti-myelin oligodendrocyte glycoprotein antibody-positive cerebral cortical encephalitis of two cases]Tomoko Tanaka, Masaya Togo, Kiminobu Okayama, et al.Journal of Neurology|January 23, 2018
Low signal intensity in motor cortex on susceptibility-weighted MR imaging is correlated with clinical signs of amyotrophic lateral sclerosis: a pilot studyHironobu Endo, Kenji Sekiguchi, Hitoshi Shimada, et al.Photochemistry and Photobiology|December 20, 2018
Characteristics of Xeroderma Pigmentosum in Japan: Lessons From Two Clinical Surveys and Measures for Patient CareChikako Nishigori, Eiji Nakano, Taro Masaki, et al.Muscle & Nerve|July 23, 2020
Progressive length-dependent polyneuropathy in xeroderma pigmentosum group AYukio Tsuji, Takehiro Ueda, Kenji Sekiguchi, et al.Neurology. Genetics|September 30, 2022
Long-Surviving Adult Siblings With Joubert Syndrome Harboring a Novel Compound Heterozygous <i>CPLANE1</i> VariantKento Matoba, Norio Chihara, Wataru Satake, et al.BMJ Open|March 22, 2023
Clinical trial on the efficacy and safety of NPC-15 for patients with xeroderma pigmentosum exaggerated sunburn reaction type: XP-1 study protocol for a multicentre, double-blinded, placebo-controlled, two-group crossover study followed by a long-term open study in JapanMariko Tsujimoto, Yasumasa Kakei, Nozomi Yamano, et al.Journal of Neurology|March 19, 2022
Clinical and pathological characteristics of later onset multiple system atrophyHiroaki Sekiya, Shunsuke Koga, Yoshihisa Otsuka, et al.Immunological Medicine|January 18, 2024
Efficacy and safety of mycophenolate mofetil for steroid reduction in neuromyelitis optica spectrum disorder: a prospective cohort studyRitsu Akatani, Norio Chihara, Shusuke Koto, et al.Internal Medicine (Tokyo, Japan)|August 2, 2021
Immunotherapy-responsive Non-paraneoplastic Encephalitis with Antibodies against GAD, LGI1, and GABA<sub>A</sub> ReceptorTakahiro Nakano, Norio Chihara, Kento Matoba, et al.Pageof 3